logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation

Shandong Fengyuan Chemical (002805.SZ) the actual controller, Zhao Guanghui, has released a pledge of 23.8 million shares.

date
17:56 07/09/2023
avatar
GMT Eight
"Shandong Fengyuan Chemical (002805.SZ) announced that it has recently received a notification from its controlling shareholder and actual controller, Zhao Guanghui, stating that all of his pledged 23.80 million shares (8.50% of the company's total shares) have been released from the pledge."
Related Articles
US Stock Market Move | Ticketplus Ltd (TP.US) debuted on the U.S. stock market, dropping over 15% after opening.
US Stock Market Move | Latigo Biotherapeutics (LTGO.US) debuts on the U.S. stock market, with its stock price rising over 14% after opening.
In July, the U.S. non-farm payroll unexpectedly turned negative, dealing a heavy blow to the dollar. The market has lowered its expectations for a rate hike in September, and the Federal Reserve may continue to hold its position.
US Stock Market Move | Ticketplus Ltd (TP.US) debuted on the U.S. stock market, dropping over 15% after opening.
US Stock Market Move | Latigo Biotherapeutics (LTGO.US) debuts on the U.S. stock market, with its stock price rising over 14% after opening.
In July, the U.S. non-farm payroll unexpectedly turned negative, dealing a heavy blow to the dollar. The market has lowered its expectations for a rate hike in September, and the Federal Reserve may continue to hold its position.
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.